ea0020p457 | Obesity and Metabolism | ECE2009
Tishova Yuliya
, Kalinchenko Svetlana
, Novikova Maria
, Shilov Evgeniy
, Borisov Vladimir
, Saad Farid
Introduction: Hyperfiltration (HF) is an early marker of chronic renal disease (CRD), which is prevalent in 1015% of MS patients\. Taking into account the benefit of testosterone replacement towards MS components in men with MS and hypogonadism, we can expect the same benefit on HF.Objective: To study the role of hypogonadism correction in patients with MS and hyperfiltration.Methods: Of 71 men aged 3569 with MS (IDF cr...